Detalles de la búsqueda
1.
Cost-Effectiveness of a Specialized Breathlessness Service Versus Usual Care for Patients With Advanced Diseases.
Value Health
; 26(1): 81-90, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36182632
2.
Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study.
Infection
; 51(3): 749-757, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083405
3.
The impact of the COVID-19 pandemic on processes, resource use and cost in palliative care.
BMC Palliat Care
; 22(1): 36, 2023 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37024852
4.
Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire.
Respir Res
; 23(1): 18, 2022 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093079
5.
Lymphocytes and sinus histiocytosis in tumor and matched lymph nodes as predictors of survival in non-small-cell lung cancer.
Future Oncol
; 18(4): 481-489, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023359
6.
Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast-track randomised controlled trial (BreathEase).
Eur Respir J
; 58(2)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33509957
7.
NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor Therapy.
Respiration
; 95(3): 169-176, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29190621
8.
Correction to: The impact of the COVID-19 pandemic on processes, resource use and cost in palliative care.
BMC Palliat Care
; 22(1): 56, 2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37161423
9.
Daily Routine and Access to Care: Initial Patient Reported Experiences at a German Lung Cancer Center during the COVID-19 Pandemic.
Respiration
; 100(1): 90-92, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33370724
10.
[Cystic fibrosis in childhood and adulthood]. / Mukoviszidose im Kindes- und im Erwachsenenalter.
Inn Med (Heidelb)
; 2024 May 07.
Artículo
en Alemán
| MEDLINE | ID: mdl-38714556
11.
Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis.
J Cyst Fibros
; 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38508948
12.
Dermal Filler Injections Mimic Tumor Activity during Immune Checkpoint Inhibition.
Respiration
; 95(5): 362-363, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29621778
13.
Risk of pneumothorax in Birt-Hogg-Dubé syndrome during pregnancy and birth.
Front Med (Lausanne)
; 10: 1289948, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38020174
14.
Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis.
Front Pharmacol
; 14: 1179208, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37153809
15.
Delayed diagnosis of Birt-Hogg-Dubé syndrome might be aggravated by gender bias.
EClinicalMedicine
; 51: 101572, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35875814
16.
Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies.
Ther Adv Med Oncol
; 13: 17588359211018028, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34178120
17.
Colorectal cancer risk in families with Birt-Hogg-Dubé syndrome increased.
Eur J Cancer
; 151: 168-174, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000505
18.
Genetic Risk Factors for Spontaneous Pneumothorax in Birt-Hogg-Dubé Syndrome.
Chest
; 157(5): 1199-1206, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31958439
19.
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations.
Oncol Res Treat
; 43(6): 289-298, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32268332
20.
Excellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studies.
AME Case Rep
; 3: 36, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31728434